by Michele W. Berger, University of Pennsylvania Around the world, some 50 million people have epilepsy, with more than 3 million in the United States alone. It’s one of the most common neurological diseases globally, characterized by recurrent seizures in part or all of the body. It’s also quite treatable with daily antiseizure medications. Yet like...
COLUMBUS, Ohio – In an effort to better understand neurological diseases like Alzheimer’s, Parkinson’s and ALS – and develop new ways to treat them – researchers at The Ohio State University Wexner Medical Center have performed the first meta-analysis of all induced pluripotent stem cell models for neurological and neurodegenerative diseases, and created an atlas of how...
A new kind of antibody targets a feature shared by proteins thought to cause the most damage in Alzheimer’s disease, Parkinson’s disease, and related conditions, creating potential for a unified treatment approach. This is the finding of a study led by researchers from NYU School of Medicine and published online August 29 in Scientific Reports. The...
